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Abstract
Adipose‐derived	stem	cells	(ADSCs)	possess	multipotent	properties,	and	their	proper	
functionality	is	essential	for	further	development	of	metabolic	disorders.	In	the	cur‐
rent	study,	we	explored	the	impact	of	two	n‐3	LC‐PUFAs	(long‐chain	polyunsaturated	
fatty	acids,	DHA—docosahexaenoic;	C22:6,	and	EPA—eicosapentaenoic;	C20:5)	on	a	
specific	profile	of	lipolytic‐related	gene	expressions	in	the	in	vitro‐differentiated	sub‐
cutaneous	and	visceral	ADSCs	from	rabbits.	The	subcutaneous	and	visceral	ADSCs	
were	obtained	 from	28‐day‐old	New	Zealand	 rabbits.	 The	primary	 cells	were	 cul‐
tured	up	to	passage	4	and	were	induced	for	adipogenic	differentiation.	Thereafter,	
the	differentiated	cells	were	treated	with	100	µg	EPA	or	DHA	for	48	hr.	The	total	
mRNA	was	 isolated	 and	 target	 genes	expression	evaluated	by	 real‐time	RCR.	The	
results	demonstrated	that	treatment	of	rabbit	ADSCs	with	n‐3	PUFAs	significantly	
enhanced	mRNA	expression	of	Perilipin	A,	while	the	upregulation	of	leptin	and	Rab18	
genes	was	seen	mainly	 in	ADSCs	 from	visceral	adipose	 tissue.	Moreover,	 the	EPA	
significantly	enhanced	PEDF	(Pigment	Derived	Epithelium	Factor)	mRNA	expression	
only	in	visceral	cells.	Collectively,	the	results	suggest	activation	of	an	additional	lipol‐
ysis	pathway	most	evident	in	visceral	cells.	The	data	obtained	in	our	study	indicate	
that	in	vitro	EPA	up‐regulates	the	mRNA	expression	of	the	studied	lipolysis‐associ‐
ated	genes	stronger	than	DHA	mainly	in	visceral	rabbit	ADSCs.
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1  | INTRODUCTION
Previously,	adipose	tissue	was	considered	an	inert	energy	depot,	but	
it	is	now	known	that	this	tissue	is	a	unique	endocrine	organ	(Kershaw	
&	Flier,	 2004;	 Slavov	&	Dzhelebov,	 2010).	 It	 regulates	 energy	ho‐
moeostasis	(Choe,	Huh,	Hwang,	Kim,	&	Kim,	2016)	and	significantly	
affects	the	metabolic	processes	in	the	entire	organism	through	se‐
cretion	of	different	adipokines	(Trayhurn	&	Beattie,	2001;	Wozniak,	
Gee,	Wachtel,	&	Frezza,	2009).
Disturbances	 in	 adipose	 tissue	 function	 are	 associated	 with	
development	of	visceral	obesity,	metabolic	syndrome	 (MS),	 insu‐
lin	resistance,	hypertension,	dyslipidemia,	cardiovascular	diseases	
etc.	 (Laclaustra,	Corella,	&	Ordovas,	2007;	Georgiev	et	al.,	2011)	
in	 humans	 and	 animals.	 These	metabolic	 disorders	 occur	 due	 to	
changes	in	energy	status	and	imbalance	of	regulatory	molecules.	
The	increased	energy	intake	leads	to	obesity,	which	is	manifested	
not	only	by	an	increase	in	the	body	fat	depots,	but	also	by	remod‐
elling	 of	 adipose	 tissue	 (Choe,	 Huh,	 Hwang,	 Kim,	 &	 Kim,	 2016).	
There	 are	many	 changes	 both	 in	 the	 number	 and	 size	 of	 adipo‐
cytes,	but	the	most	important	is	the	altered	function	of	stem	cells	
in	 adipose	 tissue,	which	 aims	 to	maintain	 the	 energy	 balance	 in	
the	body	(Choe	et	al.,	2016;	Penchev	et	al.,	2017).	The	functional	
plasticity	 of	 those	 cells	 is	 essential	 for	 further	 development	 of	
metabolic	disorders,	due	to	their	involvement	in	adipogenesis	and	
in	 production	 of	 adipose‐derived	 cytokines,	 hormones	 and	 me‐
tabolites.	In	this	sense,	the	stem	cells	in	adipose	tissue	appear	as	
an	appropriate	target	for	therapy	and	reveal	possibilities	for	ma‐
nipulating	 cell	 response	 in	 prevention	 of	 related	 disorders	 using	
exogenous	factors.
The	 process	 of	 differentiation	 of	 preadipocytes	 into	 mature	
adipocytes	 is	manifested	by	 the	 formation	of	 lipid	 droplets	 in	 cell	
cytoplasm.	This	transition	is	initiated	and	regulated	by	some	adipo‐
genic	 transcription	 factors,	 such	 as	 peroxisome	 proliferator‐acti‐
vated	receptor	γ	(PPARγ)	(Schoonjans,	Staels,	&	Auwerx,	1996).	The	
subsequent	maintenance	of	fat	droplets	in	the	mature	adipocytes	is	
a	 result	of	 the	balance	between	the	reactions	supplying	free	fatty	
acids	(FFA)	for	triacylglycerol	(TAG)	synthesis	in	adipose	cells	(lipo‐
protein	 lipase—LPL,	 catalysing	 the	 TAG	 hydrolysis	 in	 lipoproteins)	
and	enzymes	 involved	 in	 lipolysis	 (breaking	down	of	TAG	 in	 cells).	
The	most	 important	enzymes	catalysing	 the	 latter	process	are	ad‐
ipose	 triglyceride	 lipase	 (ATGL,	 known	 as	 desnutrin),	 encoded	 by	
Pnpla2gene,	 and	 hormone‐sensitive	 lipase	 (HSL),	 encoded	 by	 Lipe 
gene	 (Zimmermann	 et	 al.,	 2004;	 Ahmadian,	 Wang,	 &	 Sul,	 2010).	
The	 activity	 of	 these	 lipolytic	 enzymes,	 responsible	 for	 decreas‐
ing	 the	 levels	 of	 TAGs	 in	 the	 cells,	 is	 subordinated	with	 a	 protein	
in	the	fat	droplets	shell—Perilipin	A	(a	lipid	droplet	scaffold	protein)	
(Brasaemle	et	al.,	2000).	Perilipin	A	is	regulated	by	PPARγ	on	a	tran‐
scriptional	level,	indicating	the	importance	of	this	mechanism	in	the	
processes	of	formation	and	growth	of	the	fat	droplets	in	adipocytes	
(Arimura,	Horiba,	Imagawa,	Shimizu,	&	Sato,	2004).
In	 terms	 of	 dietetics,	 the	 quality	 of	 dietary	 fat	 and	 the	 content	
of	 long‐chain	 polyunsaturated	 fatty	 acids	 (LC‐PUFAs),	 particularly	
omega‐3	(ω‐3	or	n‐3),	is	of	great	importance.	Among	the	n‐3	PUFAs,	
docosahexaenoic	 (DHA;	 C22:6)	 and	 eicosapentaenoic	 (EPA;	 C20:5)	
acids	 are	 shown	 to	 decrease	 lipogenesis	 and	 to	 stimulate	 lipolysis	
(Todorčević	&	Hodson,	2016),	but	the	molecular	mechanisms	of	these	
molecules	on	transcriptional	regulation	remain	unclear.	EPA	is	known	to	
be	an	agonist	and	regulator	of	the	PPARγ	gene	expression	(Chambrier	
et	al.,	2002),	while	DHA	was	proven	to	increase	mitochondrial	biogen‐
esis	through	PPARγ	upregulation	in	human	adipose‐derived	stem	cells	
(hADSCs)	from	subcutaneous	fat	depots	(Chen	et	al.,	2015).
Having	in	mind	that	all	aforementioned	factors	are	key	regulators	
and/or	modulators	of	lipolysis,	in	this	study	we	designed	a	panel	of	lip‐
olysis‐related	genes	which	include	8	genes	and	examined	the	changes	
of	their	expression	after	incubation	of	ADSCs	with	two	n‐3	LC‐PUFAs	
(DHA	and	EPA).	The	obtained	correlations	would	clarify	whether	the	
cell	exposure	to	PUFAs	has	an	agonistic	or	antagonistic	effect	on	the	
PPARγ‐regulated	metabolic	pathways	in	lipid	metabolism.	While	rab‐
bits	are	considered	as	appropriate	animal	models	for	studying	some	
obesity‐related	disorders	(Aguilera,	Ramirez‐Tortosa,	Mesa,	Ramirez‐
Tortosa,	&	Gil,	2002;	Yanni,	2004),	the	current	study	provides	useful	
information	for	n‐3–PUFAs	dependent	specific	gene	expression	pro‐
file,	implemented	for	MS	prevention	in	humans	and	animals.
2  | MATERIAL AND METHODS
2.1 | Animals and cell isolation procedure
The	cells	were	obtained	from	three	28‐day‐old	New	Zealand	rabbits.	
The	animals	were	euthanized	in	accordance	with	the	recommenda‐
tions	and	approval	of	the	Local	Committee	for	Humane	Treatment	
of	 Animals.	 Isolation	 procedure	 was	 carried	 out	 as	 described	 by	
Vachkova	et	al.	(2016).	Briefly,	the	samples,	weighing	1–1.5	g	each,	
were	 collected	 from	 the	 subcutaneous	 (interscapular	 region)	 and	
visceral	 (perirenal	 region)	 fat	 depots,	 minced	 into	 fine	 pieces	 and	
digested	 with	 collagenase.	 Followed	 centrifugation	 at	 300	g	 for	
10	min,	the	pellet	was	re‐suspended,	seeded	into	T25	tissue	flasks	
in	DMEM	 (Dulbecco's	Modified	Eagle's	Medium),	10%	FBS	 (Foetal	
Bovine	Serum)	and	antibiotic	mixed	solution	(pen/strep/amphoB)	all	
from	Sigma	(St.	Louis,	MO,	USA)	and	incubated	under	humidified	5%	
CO2	 conditions	 at	 37.5°C	 until	 reaching	 confluence.	 The	 achieved	
cells	were	cultured	up	to	passage	4	and	were	used	for	the	experi‐
ment.	The	experiment	was	duplicated.
2.2 | Adipogenic differentiation and 
experimental design
The	 harvested	 subcutaneous	 and	 visceral	 ADSCs	were	 seeded	 at	
5 × 104/ml	density,	cultured	in	12‐well	plates	with	basal	medium	for	
3	days	until	the	monolayer	became	confluent.	After	that	period,	the	
cells	were	kept	for	an	additional	24	hr	for	growth	arrest	and	treated	
with	 DMEM	 (high	 glucose),	 10%	 FBS,	 0.1	mM	 3‐Isobutyl‐1‐meth‐
ylxanthine	 (IBMX),	 0.05	mM	 indomethacin,	 1	μM	 dexamethasone,	
10 μg/ml	insulin	and	antibiotic	mixed	solution	(pen/strep/amphoB),	
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all	from	Sigma	(St.	Louis,	MO,	USA),	for	3	days.	On	the	third	day,	the	
medium	was	replaced	with	DMEM	(high	glucose),	10%	FBS,	10	μg/
ml	 insulin	and	antibiotic	mixed	solution	(pen/strep/amphoB)	for	an	
additional	 three	 days.	 In	 total,	 this	 inducing/maintenance	medium	
cycle	was	performed	three	times	 in	order	 to	 fulfil	 the	adipose	dif‐
ferentiation	programme	(Bosnakovski	et	al.,	2005).
At	this	stage,	the	experimental	groups	were	formed	as	follows:	
control	group,	treated	with	DMEM;	10%	FBS,	antibiotic	mixed	solu‐
tion	 (pen/strep/amphoB);	EPA‐group,	treated	with	control	medium	
+100	µg	EPA	and	DHA‐group,	treated	with	control	medium	+100	µg	
DHA.	 All	 groups	were	 treated	 for	 48	hr.	 In	 the	 current	 study,	we	
used	 DHA	 (with	 purity	 ≥98%)	 and	 EPA	 (with	 purity	 ≥99%).	 Stock	
solutions	were	 prepared	 by	 solving	 the	 PUFAs	 in	 sterile,	 cell	 cul‐
ture‐tested	ethanol	(all	from	Sigma‐Aldrich)	and	aliquots	were	kept	
in	dark	conditions	at	−20°C.	For	the	experimental	 treatment,	each	
PUFA	additionally	diluted	ex	tempore	in	control	medium	up	to	final	
concentration	of	100	µg/ml	while	ethanol	reached	final	dilution	of	
1,000‐fold.
2.3 | Other methods, related to multipotency 
verification
In	 addition	 to	 the	main	 experiment,	 the	 cells	 from	both	 visceral	
and	 subcutaneous	 types	were	 seeded	 in	24‐well	 plates	with	 av‐
erage	 density	 5	×	104/ml	 and	 cultivated	 in	 basal	medium,	 under	
humidified	5%	CO2	conditions	at	37.5°C	until	reaching	confluence.	
The	 subsequent	 differentiation	 and	 staining	 procedures	 were	
performed,	 and	 the	 results	 were	 documented	 by	microscopy	 as	
follow:
2.3.1 | Adipogenic differentiation and Oil Red 
O staining
After	 finishing	 the	 triplicated	 cycle	 of	 induction/maintenance	me‐
dium	treatment,	the	cells	were	washed	with	PBS	and	fixed	with	10%	
(vol/vol)	neutral	buffered	formalin	for	30	min	at	room	temperature.	
A	freshly	prepared	working	solution	of	Oil	Red	O	(Sigma,	St.	Louis,	
F I G U R E  1  Functional	multipotency	of	subcutaneous	and	visceral	ADSCs:	the	samples	and	their	negative	controls	stained	with	Oil	
Red	O	for	adipogenesis	(Bar	=	200	μm);	the	samples	stained	with	Alizarin	Red	for	osteogenesis	(Bar	=	350	μm)	and	their	negative	controls	
(Bar	=	200	μm);	the	samples	for	chondrogenesis	stained	with	Alcian	blue	(Bar	=	50	μm)		[Colour	figure	can	be	viewed	at	wileyonlinelibrary.com]
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MO,	USA)	was	applied,	and	cells	were	incubated	for	30	min	at	a	room	
temperature.	 Subsequently,	 the	 stain	 was	 removed	 and	 the	 wells	
were	washed	with	distilled	water.
2.3.2 | Osteogenic differentiation
After	 the	 initial	 expansion,	 the	cells	were	kept	an	additional	24	hr	
for	 growth	 arrest	 and	 treated	with	osteogenic	 differentiation	me‐
dium,	containing	DMEM;	10%	FBS,	0.1	μM	dexamethasone;	10	mM	
β‐glycerolphosphate;	 50	µM	 L‐ascorbic	 acid	 and	 antibiotic	 mixed	
solution	 (pen/strep/amphoB),	 all	 from	Sigma	 (St.	 Louis,	MO,	USA),	
for	a	period	of	21	days.	The	medium	was	changed	every	three	days.	
Alizarin	Red	S	staining	with	pH	4.2	visualized	the	extracellular	cal‐
cium	deposits	in	ADSCs	in	bright	orange	red,	indicating	early	stages	
of	bone	formation.
2.3.3 | Chondrogenic differentiation
The	 chondrogenesis	 was	 performed	 in	 “pellet”	 culture	 system	
(Bosnakovski	et	al.,	2004)	by	centrifugation	of	cells	at	a	density	of	
2 × 105/ml	at	400	g	for	10	min.	The	cells	were	treated	with	serum‐
free	 basal	 medium,	 supplemented	 with	 10	ng/ml	 TGFβ‐1	 (R&D	
Systems,	 Inc.;	Minneapolis,	MN	USA),	 0.1	μM	dexamethasone	 and	
50	µM	l‐ascorbic	acid.	The	medium	was	changed	every	third	day	for	
a	21‐day	period.	The	cells	were	stained	 in	Alcian	blue	and	treated	
with	 0.1	M	HCl,	 for	 5	min	 for	 detection	 of	 extracellular	 cartilage‐
specific	 proteoglycans.	 Samples	embedded	 in	 gelatin	 and	 cryostat	
sections	with	thickness	6	µm	were	obtained.
Negative controls (NC)
Fibroblasts	obtained	from	rabbit	kidney	were	used	as	negative	con‐
trols	during	adipogenic,	osteogenic	and	chondrogenic	differentiation.
The	images	(Figure	1)	were	taken,	using	an	inverted	Telaval	Carl	
Ziess	JENA	 (Germany)	microscope	equipped	with	a	MDCE‐5	high‐
resolution	ocular	camera	(China).
2.4 | Gene expression analysis
The	total	RNA	was	isolated	and	purified	using	RNeasy	Lipid	Tissue	
Kit	from	Qiagen	(Hilden,	Germany)	according	to	the	manufacturer's	
protocol.	The	quality	and	quantity	of	total	RNA	was	determined	by	
ultraviolet	 absorbance	 at	 260	 and	 280	nm	with	GeneQuant	 1300	
Spectrophotometer	(GE	Healthcare	Bio‐Sciences	AB,	Sweden).
Total	 RNA	 was	 used	 for	 first‐strand	 cDNA	 synthesis	 by	 the	
RevertAid	First	Strand	cDNA	Synthesis	Kit	(Fermentas	Life	Science,	
Thermo	Fisher	Scientific™)	according	to	the	manufacturer's	instruc‐
tions.	 Reverse	 transcription	 was	 performed	 on	 a	 Quanta	 Biotech	
QB‐96	 (Quanta	 Biotech	 Ltd.,	 Surrey,	 United	Kingdom).	 The	 cDNA	
was	stored	at	−20°C.
The	 ABI	 Prism	 7900H	 sequence	 detection	 system	 (Applied	
Biosystems,	Foster	City,	CA)	was	used	for	the	real‐time	PCR	reaction.	
It	was	run	 in	384‐well	Multiply	PCR	plates	 (Sarstedt	 Inc.,	Newton,	
USA),	using	SYBR	Select	Master	Mix	from	Applied	Biosystems	and	 T
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gene‐specific	primers	from	Sigma‐Aldrich	(Table	1).	The	primers	for	
target	and	housekeeping	genes	(Table	1)	were	designed	using	pub‐
lished	 data	 in	 NCBI	 (www.ncbi.nlm.nih.gov)	 and	 Ensembl	 (www.
ensambl.org).	The	product	length	and	annealing	temperatures	were	
determined	by	web‐based	software	Primer	3	 (http://bioinfo.ut.ee/
primer3/).	Standard	curves	were	created	basing	on	serial	dilutions	
of	pooled	cDNA.	The	NormFinder	software	(http://moma.dk/norm‐
finder‐software)	was	used	for	estimation	the	best	reference	gene/
combination	of	genes.	The	best	stability	value	(0.161)	was	obtained	
for	 the	 combination	 of	 Hypoxanthine	 phosphoribosyl	 transferase	
(HPRT)	 and	 Glyceraldehyde	 3‐phosphate	 dehydrogenase	 (GAPDH)	
genes.	The	ADSC	mRNA	was	normalized	to	the	arithmetic	mean	of	
HPRT and GAPDH,	which	were	used	as	housekeeping	genes,	and	sub‐
sequent	statistical	analysis	was	performed.
2.5 | Statistical analysis
All	 statistical	 analyses	 were	 performed	 with	 the	 raw	 data	 after	
normalization	 to	 the	 housekeeping	 genes,	 applying	 Statistica	 v.10	
(StatSoft	 Inc.,	1984–2011).	The	Mann–Whitney	U	test	was	carried	
out	for	estimation	of	the	differences	 in	expression	of	target	genes	
between	 two	 independent	groups.	The	 results	were	presented	by	
relative	 quantification	 of	 the	 target	 genes’	 change	 of	 expression	
from	their	relative	controls.	An	additional	Spearman's	rank	order	test	
was	used	for	determination	of	the	correlation	coefficients	(r)	within	
parameters	 in	 each	 group.	 The	 network	 analysis	 Miru	 Evaluation	
v1.4	software	(©Kajeka,	2014–2016;	https://kajeka.com)	was	used	
for	visualization	of	the	established	correlations.	For	all	tests,	p < 0.05 
was	considered	significant.
3  | RESULTS
In	order	to	express	the	functional	multipotent	properties	of	isolated	
subcutaneous	and	visceral	ADSCs,	protocols	for	adipogenic,	osteo‐
genic	and	chondrogenic	differentiation	were	applied	and	the	results	
were	presented	in	Figure	1.
After	exposure	to	DHA	(Figure	2a),	there	was	significant	increase	
in	Perilipin	A	mRNA	expression	(p	<	0.01)	in	both	subcutaneous	and	
visceral	 cells,	 compared	 to	 the	 controls,	 and	 of	 leptin	mRNA	only	
F I G U R E  2  The	data	represent	fold	changes	in	mRNA	expression	for	subcutaneous	and	visceral	cells	upon	DHA	(chart	a)	and	EPA	(chart	b)	
treatments.	With	asterisks	are	marked	the	levels	of	significance	for	each	tissue	and	treatment	type	compared	to	its	relative	control	group	as	
follow:	*p < 0.05 and **p	<	0.01.	The	significances	between	DHA	and	EPA	treatments	in	visceral	cells	are	expressed	as	number	1	(=p	<	0.05).	
The	significant	changes	between	subcutaneous	and	visceral	cells	in	DHA/EPA,	respectively,	treated	groups	are	shown	with	small	letters	a	
(=p	<	0.05)	and	b	(=p	<	0.01).	(n	=	6,	Error	Bars	=	SEM)
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in	visceral	cells	(p	<	0.01).	Similarly,	exposure	to	EPA	(Figure	2b)	re‐
sulted	in	significant	increase,	compared	with	the	controls,	of	Perilipin	
A	 mRNA	 expression	 (p	<	0.01)	 in	 both	 subcutaneous	 and	 visceral	
cells	 too,	 while	 pigment	 epithelium‐derived	 factor	 (PEDF)	 mRNA	
was	enhanced	only	in	visceral	cells	(p	<	0.05).
Significant	 differences	 between	 subcutaneous	 and	 visceral	
DHA‐treated	 cells	 were	 established	 for	 HSL	 (p	<	0.01),	 leptin	
(p	<	0.01)	 and	 Perilipin	 A	 (p	<	0.05).	 When	 comparing	 EPA‐
treated	 subcutaneous	 and	 visceral	 cells,	 there	 was	 stronger	
PPARγ	 (p	=	0.05)	 expression	 in	 subcutaneous	 cells.	 In	 visceral	
cells,	DHA	had	a	stronger	 (p	<	0.05)	 impact	on	 leptin	mRNA	ex‐
pression	 than	 EPA.	 Both	 n‐3	 PUFAs	 influenced	 Rab18	 (Ras‐re‐
lated	 protein,	 small	 Rab	GTPase)	mRNA	3‐	 to	 4‐fold	 in	 visceral	
cells	insignificantly.
With	regard	to	the	ADSCs'	origin	and	treatments,	the	data	ob‐
tained	 reveal	 different	 correlation	 dependences	 (Figure	 3).	 In	 the	
control	group	from	subcutaneous	cells,	PPARγ	correlates	positively	
with	Rab18	(r	=	0.83,	p	<	0.05)	and	HSL	(r	=	0.83,	p	<	0.05),	while	in	
visceral	cells	it	correlates	negatively	with	ATGL	(r	=	−0.89,	p	<	0.05),	
which	in	turn	is	positively	linked	with	PEDF	(r	=	0.90,	p	<	0.05).
Exposure	 to	 DHA	maintains	 the	 significantly	 positive	 PPARγ–
Rab18	 (r	=	0.90,	 p	<	0.05)	 correlation	 and	 leads	 to	 ATGL–leptin	
(r	=	0.89,	 p	<	0.05)	 interaction	 in	 subcutaneous	 cells	 (Figure	 3a).	
In	 visceral	 cells,	DHA	 (Figure	 3b)	 treatment	 resulted	 in	 significant	
positive	 Rab18–PI3K	 (phosphatidylinositide	 3‐kinases)	 (r	=	0.94,	
p	<	0.05)	 and	 Rab18–Perilipin	 A	 (r	=	0.83,	 p	<	0.05)	 correlations,	
while	 the	 PPARγ–ATGL	 relationship	 was	 still	 negative	 (r	=	−0.94,	
p	<	0.01).
F I G U R E  3  Correlation	coefficient	(r)	within	mRNA	expression	of	HSL,	ATGL,	PPARγ,	Perilipin	A,	Leptin,	PEDF,	Rab	18	and	PI3K	in	
subcutaneous	and	visceral	ADSCs	form	rabbits	(red	lines	indicate	r	>	0.80),	treated	with	DHA	(a	and	b)	and	EPA	(c	and	d)		[Colour	figure	can	
be	viewed	at	wileyonlinelibrary.com]
(a) SubcutaneousDHA (b) Visceral DHA
(c) Subcutaneous EPA (d) Visceral EPA
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When	subcutaneous	ADSCs	were	treated	with	EPA,	(Figure	3d),	
significantly	positive	relationships	of	Perilipin	A	with	PI3K	(r	=	0.89,	
p	<	0.05),	Rab	18	 (r	=	0.83,	p	<	0.05)	and	PPARγ	 (r	=	0.89,	p	<	0.05)	
were	detected.	Furthermore,	while	leptin‐PEDF	correlated	positively	
(r	=	0.90,	p	<	0.05),	HSL‐ATGL	 (r	=	−0.90,	p	<	0.05)	were	negatively	
related	in	the	same	group.	Concerning	the	visceral	cells	(Figure	3d),	
EPA	caused	strong	positive	 interplay	of	PI3K	with	Rab18	 (r	=	0.90,	
p	<	0.05),	 PEDF	 (r	=	0.90,	 p	<	0.05)	 and	 HSL	 (r	=	0.90,	 p	<	0.05).	
Correlations	 were	 also	 observed	 between	 leptin	 and	 Perilipin	 A	
(r	=	0.90,	p	<	0.05),	and	PPARγ	(r	=	0.90,	p	<	0.05).
4  | DISCUSSION
In	 general,	 the	 obtained	 results	 in	 this	 study	 demonstrated	 that	
treatment	of	differentiated	rabbit	ADSCs	for	48	hr	with	n‐3	PUFAs	
in	 vitro	 caused	 switching	 and	 re‐directing	 of	 their	 transcriptional	
profile	to	expression	of	lipolysis‐related	genes.	We	established	en‐
hancement	of	mRNA	expression	of	several	cellular	genes—Perilipin	
A,	 leptin,	 PEDF	 and	Rab18	 (even	 though	 statistically	 insignificant,	
regarded	as	Rab	18	was	elevated	almost	fourfold),	mainly	in	visceral	
cells.	It	has	been	established	that	more	than	95%	of	TAG	hydrolase	
activity	 in	 murine	 white	 adipose	 tissue	 (WAT)	 is	 due	 to	 both	 en‐
zymes,	ATGL	and	HSL	(Schweiger	et	al.,	2006).	Besides,	Perilipin	A	
is	 assumed	as	one	of	 the	most	 abundant	 lipid	droplet	 (LD)‐associ‐
ated	 proteins	 (Brasaemle,	 Subramanian,	 Garcia,	 Marcinkiewicz,	 &	
Rothenberg,	2009).	 In	 the	current	study,	 it	was	 the	most	up‐regu‐
lated	 gene	 by	 both	 n‐3	 PUFAs	 and	 those	 findings	 differ	 from	 the	
results	reported	in	the	3T3	model	(Wójcik	et	al.,	2014).	We	assume	
that	the	established	changes	in	Perilipin	mRNA	could	be	due	to	spe‐
cies‐specific	response	(mice	vs.	rabbits)	to	PUFAs	exposure.	Having	
in	mind	that	 in	the	resting	period	Perilipin	A	protects	TAGs	in	LDs	
from	cytosolic	lipase	breakdown,	we	suggest	that	the	significant	up‐
regulation	of	Perilipin	A	mRNA	expression	 is	 the	cellular	 response	
upon	increased	necessity	of	TAG	storage	(Fujimoto,	Ohsaki,	Cheng,	
Suzuki,	 &	 Shinohara,	 2008).	 After	 β‐adrenergic/glucagon	 stimula‐
tion	and	activation	of	 adenylyl	 cyclase/cAMP/PKA	 (protein	kinase	
A)	pathway,	Perilipin	A	phosphorylation	is	essential	for	HSL‐depend‐
ent	lipolysis	(Sztalryd	et	al.,	2003;	Miyoshi	et	al.,	2006).	Due	to	PKA	
phosphorylation,	 Perilipin	 A	 releases	 CGI‐58	 (Comparative	 Gene	
Identification‐58),	which	is	bound	to	the	LD	membrane	(Yamaguchi,	
Omatsu,	Matsushita,	&	Osumi,	2004)	and	in	turn	co‐activates	ATGL	
in	the	initial	step	of	TAG	breakdown	(Lass	et	al.,	2006;	Lu,	Yang,	&	
Liu,	2010).	 In	this	scenario,	 if	we	assume	that	the	phosphorylation	
of	Perilipin	A	is	the	central	regulatory	hub	for	lipolytic	events	in	the	
fat	 cell	 (Duncan,	 Ahmadian,	 Jaworski,	 Sarkadi‐Nagy,	 &	 Sul,	 2007;	
Choi	et	al.,	2010),	then	we	can	suspect	a	possible	positive	 interac‐
tion	between	ATGL,	HSL	and	Perilipin	A.	We	did	not	observe	 it	 in	
any	of	treated	groups	which	could	be	explained	by	the	lack	of	β‐adr‐
energic	or	glucagon	 stimulation.	 It	has	been	 reported	 that	neither	
ATGL‐	nor	HSL‐deficiency	greatly	 influenced	the	 lipase	patterns	 in	
white	adipose	tissue.	Enzyme	activities	of	mouse	tissues	on	acylg‐
lycerol	 substrates	were	 analysed	 as	well,	 showing	 that	ATGL‐	 and	
HSL‐deficiencies	can	be	compensated	at	 least	 in	part	by	other	en‐
zymes	(Morak	et	al.,	2012).
Recently,	PEDF	has	been	defined	as	one	of	the	most	abundant	
adipokines,	 able	 to	 activate	 several	 signalling	 pathways,	which	 in	
turn	lead	to	insulin	resistance	(Borg	et	al.,	2011).	A	few	years	ago,	
Sunderland	et	al.	 (2012)	reported	that	plasma	PEDF	was	elevated	
in	overweight	youth	 (Sunderland	et	al.,	2012).	 In	our	study,	PEDF	
mRNA	was	 significantly	up‐regulated	by	EPA	only	 in	visceral,	 but	
not	in	subcutaneous	cells	(Figure	1b).	The	elevated	PEDF	could	pro‐
mote	ubiquitin–proteasome‐mediated	protein	degradation	of	ATGL	
and	this	might	contribute	to	progressive	obesity,	insulin	resistance	
and	 a	 subsequent	 negative	 correlation	 between	 PEDF	 and	 ATGL	
expression	in	obesity	(Crowe	et	al.,	2009;	Dai	et	al.,	2013).	On	the	
surface	of	 it,	 the	 increased	expression	of	PEDF	obtained	 in	EPA‐
treated	visceral	cells	could	be	assumed	as	predisposition	for	devel‐
opment	of	such	a	disturbance	in	visceral	type	of	obesity.	The	more	
profound	exploration	of	the	established	changes	reveals	different	
meaning	of	PEDF	 implication	under	diabetic	and	hypoxia‐induced	
angiogenesis	 conditions	 (He,	 Cheng,	 Benyajati,	 &	Ma,	 2015).	 The	
authors	have	reviewed	the	PEDF's	anti‐angiogenic	mechanisms	and	
its	therapeutic	potential	in	proliferative	diabetic	retinopathy.	In	this	
sense,	 though	related	to	 insulin	resistance,	 the	elevation	of	PEDF	
might	 be	 a	 protective	 and/or	 compensatory	 mechanism	 against	
obesity‐related	angiogenesis	even	in	adipose	tissue	itself.	The	find‐
ing	could	benefit	 the	expansion	of	 therapeutic	use	of	PUFAs	and	
EPA	in	particular.
Besides	 PEDF,	 leptin	 was	 also	 reported	 to	 have	 an	 autocrine	
manner	 of	 action	 in	 mice	 via	 binding	 to	 adipocyte	 leptin	 recep‐
tors	 (Frühbeck,	Aguado,	&	Martínez,	1997).	The	addition	of	 artifi‐
cially	high	doses	of	leptin	in	primary	cultures	of	porcine	adipocytes	
causes	 lipolysis,	 associated	 with	 an	 increase	 in	 AGTL	 (Li,	 Zheng,	
Liu,	&	Yang,	 2010).	 In	 bovine	 primary	 adipocytes,	 leptin	 regulates	
lipolysis	via	a	STAT3‐mediated	increase	in	ATGL	abundance	(Koltes	
&	Spurlock,	2013).	Our	 results	 confirm	 such	positive	 relation	only	
in	 subcutaneous	DHA‐treated	 cells,	 although	 the	 leptin	 and	ATGL	
mRNA	 expression	 levels	were	 not	 increased.	However,	 in	 visceral	
cells	 we	 established	 that	 DHA	 significantly	 up‐regulated	 leptin	
mRNA	expression.	The	increased	levels	of	 leptin	described	in	obe‐
sity	are	found	to	cause	insulin	resistance	mainly	by	suppression	of	
two	 processes	 leading	 to	 increase	 of	 insulin	 sensitivity,	 adiposity	
and	 lipotoxicity	 (Paz‐Filho,	 Mastronardi,	 Wong,	 &	 Licinio,	 2012).	
Adiponectin,	on	opposite,	 is	reduced	in	obesity	and	that	reduction	
is	associated	with	insulin	resistance,	dyslipidemia	and	atherosclero‐
sis	in	humans	(Yadav,	Kataria,	Saini,	&	Yadav,	2013).	Previously,	we	
reported	(Vachkova	et	al.,	2017)	that	DHA	up‐regulated	adiponectin	
mRNA	in	visceral	cells,	while	EPA	did	not	affect	 it.	Together	these	
data	 reveal	 that	DHA	might	have	 stronger	potential	 for	 improving	
insulin	resistance	in	visceral	obesity,	than	EPA.
Another	component	of	the	LD	coat	involved	in	insulin‐mediated	
lipogenesis	and	in	β‐adrenergic/glucagon‐induced	lipolysis	is	Rab18	
(Pulido	et	al.,	2011).	We	observed	an	upregulation	of	Rab	18	gene	
expression	and	a	strong,	significantly	positive	correlation	between	
Rab18	and	PI3K	in	visceral	DHA	and	EPA‐treated	cells.	PI3K	has	been	
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reported	as	one	of	the	central	players	in	insulin	signalling	pathways	
leading	to	metabolic	effects	 (Taniguchi,	Emanuelli,	&	Kahn,	2006).	
Moreover,	PI3K	might	also	act	downstream	of	the	insulin	receptor	
in	regulation	the	lipid	droplet	trafficking	(Choi	et	al.,	2010),	which	is	
also	affected	by	Rab18.	There	is	evidence	that	Rab18	does	not	in‐
teract	with	LDs	until	they	increase	in	size	(Ozeki	et	al.,	2005).	Rab18	
was	 identified	to	be	closely	associated	with	LDs	that	undergo	 lip‐
olysis,	which	suggests	a	supportive	role	for	ATGL	(Soni	et	al.,	2009).	
Analysing	the	PI3K	mRNA	associations	in	EPA‐treated	visceral	cells,	
we	observed	a	positive	correlation	between	it	with	PEDF	and	HSL,	
similar	to	Rab	18.	These	links	may	represent	an	increased	lipolytic	
activity	 in	 EPA‐treated	 visceral	 cells.	 In	 control	 groups,	 PI3K	 cor‐
related	with	PEDF	positively	in	subcutaneous	cells	and	negatively	in	
visceral	cells,	whereas	the	treatments	with	PUFAs	provoked	the	op‐
posite	effects.	Therefore,	the	tissue‐specific	effects	of	PUFAs	could	
be	in	part	due	to	PEDF	and	PEDF,	in	turn,	might	be	the	link	between	
subcutaneous	and	visceral	crosstalk	realized	via	PI3K.
A	limitation	of	the	study	is	the	evaluation	of	mRNA	expression	
without	 protein	 measurement,	 because	 not	 always	 up‐regulated	
mRNA	synthesis	 is	followed	by	significantly	 increased	protein	pro‐
duction.	Nevertheless,	the	obtained	experimental	data	might	bring	
a	new	light	in	understanding	the	molecular	mechanism	of	PUFAs	ef‐
fects	on	ameliorating	the	obesity‐induced	metabolic	syndrome	and	
related	diseases.
In	conclusion,	the	results	obtained	in	our	study	indicate	that	both	
DHA	and	EPA	up‐regulate	in	vitro	the	mRNA	expression	of	lipolysis‐
associated	genes,	mainly	in	visceral	rabbit	ADSCs.	Both	PUFAs	did	
not	affect	adenylyl	cyclase/cAMP/PKA‐dependent	lipolysis,	but	EPA	
augmented	PEDF	and	leptin	mRNA	expression,	which	in	turn	might	
influence	basal	lipolysis	in	rabbit	visceral	ADSCs.	The	variety	of	cor‐
relations	among	the	mRNA	levels	of	lipolytic‐associated	genes	sug‐
gests	 the	 enormous	 compensatory	 properties	 of	 visceral	 fat	 cells.	
These	findings	reveal	the	specific	gene	expression	profile	mediating	
a	lipolytic	potential	of	3‐n	PUFAs	on	ADSCs	and	their	beneficial	ef‐
fect	with	respect	to	obesity	treatment	and	MS	prevention.
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